Sweet Potato for Anti-Inflammatory

Research suggests that compounds found in sweet potato — particularly anthocyanins, polysaccharides, and polyphenols concentrated in purple-fleshed varieties — demonstrate notable anti-inflammatory activity across a range of preclinical studies, with effects observed in cell cultures and animal models involving multiple inflammation-related conditions including colitis, liver injury, rheumatoid arthritis, and systemic inflammatory responses. Studies indicate these compounds work through several overlapping molecular mechanisms, including suppression of key inflammatory signaling pathways such as NF-κB, MAPK, TLR4, and the NLRP3 inflammasome, as well as beneficial shifts in gut microbiome composition and immune cell behavior. The available evidence is entirely preclinical — drawn from laboratory cell experiments and mouse or rat models — with no randomized controlled trials or human clinical studies represented in the current body of research, which is an important limitation when considering how these findings might translate to human health. Two studies took a neutral direction, focusing on plant biochemistry and a separate viral-entry mechanism rather than inflammation directly, but the remaining studies consistently point in a supportive direction, suggesting sweet potato constituents warrant further investigation in human trials before any conclusions about therapeutic relevance can be drawn.